Newborn Screening Market worth $ 819.6 Million by 2019

1
MarketsandMarkets Presents
Newborn Screening Market worth 819.6 Million by
2019
2

• According to a new market research report,
  "Newborn Screening Market by Test Type (Dried
  Blood Spot, Hearing Screening, CCHD), Technology
  (Tandem Mass Spectrometry, Immunoassay, Enzyme
  Assay, Electrophoresis, Pulse Oximeter),
  Instrument, Accessories, Reagent Assay Kit
  Global Forecast to 2019" The global newborn
  screening market was valued at an estimated
  438.9 million in 2013 and is expected to reach
  819.6 million by 2019, growing at a CAGR of
  11.0 between 2013 and 2019.
• Browse 70 market data tables and 16 figures
  spread through 242 pages and in-depth TOC on
  "Newborn Screening Market by Test Type (Dried
  Blood Spot, Hearing Screening, CCHD), Technology
  (Tandem Mass Spectrometry, Immunoassay, Enzyme
  Assay, Electrophoresis, Pulse Oximeter),
  Instrument, Accessories, Reagent Assay Kit
  Global Forecast to 2019.
• http//www.marketsandmarkets.com/Market-Reports/ne
  wborn-screening-market-141676244.html

3

Early buyers will receive 10 customization on
Reports.
4

• The report segments this market based on type,
  technology, product and geography. Among various
  technologies, the enzyme assays and immunoassays
  commanded the largest share in 2013, while tandem
  mass spectrometry is forecasted to be the
  fastest-growing segment in this market. Factors
  such as benefits offered by newborn screening
  programs, legislations and mandates,
  technological advancements, government support,
  and expanding panel of newborn diseases are
  driving the growth of the market. Furthermore,
  owing to continuous advancements in technology,
  new and innovative devices are being launched in
  the market, which is another major factor
  providing impetus for growth of the market.
• Based on geography, the global market is
  segmented into North America, South America,
  Europe, Asia, and the Rest of the World (RoW).
  North America accounted for the largest share of
  the market in 2013. This large share of the North
  American region can be attributed to the
  government support in terms of formation of
  legislation, grants and funding, need for
  reducing healthcare cost and rising awareness.

5

• The prominent players in this market are AB SCIEX
  (U.S.), Agilent Technologies (U.S.), Bio-Rad
  Laboratories (U.S.), Covidien PLC (Ireland), GE
  Life Sciences (U.K.), Masimo Corporation (U.S.),
  Natus Medical Inc. (U.S.), PerkinElmer Inc.
  (U.S.), Trivitron Healthcare (India), and Waters
  Corporation (U.S.).

6
About MarketsandMarkets
Markets and Markets is a global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. Markets and Markets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotive and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at Markets and
Markets are inspired to help our clients grow by
providing apt business insight with our huge
market intelligence repository.
7
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Blog http//twitter.com/marke
tsmarkets
http//www.linkedin.com/company/marketsandmarkets